Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
10x Genomics, Inc. (TXG)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 1.6 | 2.6 | 5.1 | 4.3 | |
Asset turnover | 0.5 | 0.4 | 0.7 | 1.5 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -23.7% | -57.1% | -33.4% | -229.0% | |
ROIC (including intangibles) | -16.2% | -48.6% | -20.6% | -141.2% | -229.8% |
ROE | -6.9% | -11.9% | -7.3% | -208.3% | -40.1% |
ROA | -5.6% | -9.5% | -5.1% | -39.0% | -24.3% |
|
Cash Conversion Cycle |
Days sales outstanding | 63.4 | 62.5 | 49.5 | 70.1 | 68.5 |
Days payables outstanding | 85.5 | 29.4 | 77.9 | 112.0 | 188.1 |
Days inventory outstanding | 295.4 | 187.0 | 91.3 | 109.1 | 167.2 |
Cash conversion cycle | 273.4 | 220.2 | 62.9 | 67.2 | 47.6 |
|